Knocking out TYROBP in our mice did not alter expression of FTO or ALKBH5, consistent with a report of normal FTO and ALKBH5 levels in soluble and insoluble hippocampal fractions from AD patients (Huang et al., 2020). This evidence concerns the gene FTO and Alzheimer disease.